Morris Benveniste Selected Research

1,4-dihydroquinone

1/2014

Pharmacological correction of gating defects in the voltage-gated Ca(v)2.1 Ca²⁺ channel due to a familial hemiplegic migraine mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Morris Benveniste Research Topics

Disease

2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021 - 11/2017
1	Migraine with Aura (Familial Hemiplegic Migraine) 01/2014
1	Scorpion Stings 10/2010
1	Paralysis (Palsy) 10/2010
1	Neuralgia (Stump Neuralgia) 06/2007
1	Pain (Aches) 06/2007
1	Visceral Pain 06/2007
1	Chronic Pain 06/2007
1	Hyperalgesia 06/2007
1	Stroke (Strokes) 01/2005

Drug/Important Bio-Agent (IBA)

2	Pilocarpine (Ocusert)FDA LinkGeneric 01/2021 - 11/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014
1	voltage-dependent calcium channel (P-Q type)IBA 01/2014
1	1,4-dihydroquinoneIBA 01/2014
1	Scorpion Venoms (Scorpion Venom)IBA 10/2010
1	Sodium Channels (Sodium Channel)IBA 10/2010
1	Freund's AdjuvantIBA 06/2007
1	Streptozocin (Streptozotocin)FDA Link 06/2007
1	Sulpiride (neogama)IBA 06/2007
1	quinone (benzoquinone)IBA 06/2007
1	Phenyl-P adhesion promoting monomerIBA 06/2007
1	bicifadineIBA 06/2007
1	KaolinIBA 06/2007
1	AcidsIBA 01/2005

Therapy/Procedure

1	Therapeutics 10/2010
1	Ligation 06/2007